Foy,
Gabexate,
Gabexate Mesilate,
Gabexate Mesylate,
Gabexate Methanesulfonate,
Gabexate Monomethanesulfonate,
Gabexate Monomethanesulfonate, 14C Labeled Cpd,
Gabexate Monomethanesulfonate, 14C-Labeled Cpd,
Mesilate, Gabexate,
Mesylate, Gabexate,
Methanesulfonate, Gabexate,
Monomethanesulfonate, Gabexate,
Gabexate mesylate,
56974-61-9,
Gabexate mesilate,
Gabexate monomethanesulfonate,
Gabexate (mesylate),
Megacart,
Gabexate Methanesulfonate,
FOY,
39492-01-8,
MFCD00210299,
UNII-E3Q07L0649,
NCGC00017121-01,
CPD000058918,
CAS-56974-61-9,
DSSTox_CID_25591,
DSSTox_RID_80986,
DSSTox_GSID_45591,
C17H27N3O7S,
4-[[6-[(aminoiminomethyl)amino]-1-oxohexyl]oxy]benzoic acid ethyl ester mesylate,
4-[[6-[(Aminoiminomethyl)amino]-1-oxohexyl]oxyl]benzoic acid ethyl ester mesylate salt,
SMR000058918,
E3Q07L0649,
SR-01000597763,
Arodate,
Megacert,
Mesyl Gabexate,
gabexate-mesylate,
Arodate (TN),
PubChem4068,
AC1O7GMA,
Gabexate mesilate (JP17),
MLS001401400,
MLS002222309,
MLS006010132,
SCHEMBL317799,
CHEMBL1398351,
DTXSID0045591,
CHEBI:31641,
FOY-S 983,
KS-00000XPD,
FOY 007,
HMS1571I17,
HMS2051A22,
HMS2098I17,
HMS2230M20,
HMS3268G12,
HMS3370J02,
HMS3393A22,
HMS3655F19,
HMS3676H16,
HMS3715I17,
BCP13557,
HY-B0385,
Tox21_110789,
AC-467,
AKOS015889904,
AKOS025402087,
Tox21_110789_1,
API0024746,
CCG-100903,
CCG-221008,
CS-2457,
KS-1203,
NC00153,
VA10991,
ACM39492018,
NCGC00025297-04,
AK323635,
BC208332,
SAM001246730,
SMR002530330,
AB2000505,
FT-0630694,
G0464,
SW197284-3,
D01672,
J10214,
492G018,
A831268,
C-22025,
I06-0358,
SR-01000597763-1,
SR-01000597763-2,
56974-61-9 39492-01-8(base),
ethyl 4-(6-guanidinohexanoyloxy)benzoate methanesulfonate,
Gabexate mesylate, analytical standard, for drug analysis,
ethyl 4-((6-guanidinohexanoyl)oxy)benzoate methanesulfonate,
4-[[6-[(aminoiminomethyl)amino]-1-oxohexyl]oxy]-benzoic acid ethyl ester mesylate,
4-[6-(diaminomethylideneamino)-1-oxohexoxy]benzoic acid ethyl ester; methanesulfonic acid,
ethyl 4-[6-(diaminomethylideneamino)hexanoyloxy]benzoate; methanesulfonic acid,
ethyl 4-[6-[bis(azanyl)methylideneamino]hexanoyloxy]benzoate; methanesulfonic acid,
4-[[6-[(Aminoiminomethyl)amino]-1-oxohexyl]oxy]benzoic Acid Ethyl Ester Mesylate / Gabexate Methanesulfonate,
4-[[6-[(Aminoiminomethyl)amino]-1-oxohexyl]oxy]benzoic Acid Ethyl Ester Monomethanesulfonate,
Benzoic acid, 4-[[6-[(aminoiminomethyl)amino]-1-oxohexyl]oxy]-, ethylester, monomethanesulfonate,
gabexate,
null,
Gabexato,
Gabexatum,
Gabexato mesilato,
Mesilate, Gabexate,
Mesylate, Gabexate,
Gabexate [INN],
Gabexatum [INN-Latin],
Gabexato [INN-Spanish],
Gabexate mesilate [JAN],
Methanesulfonate, Gabexate,
Gabexato mesilato [Spanish],
Monomethanesulfonate, Gabexate,
UNII-4V7M9137X9,
56974-61-9 (mesylate),
C16H23N3O4.CH4O3S,
s2101,
C16-H23-N3-O4,
CID6604561,
C16-H23-N3-O4.C-H4-O3-S,
Gabexate Monomethanesulfonate, 14C Labeled Cpd,
Gabexate Monomethanesulfonate, 14C-Labeled Cpd,
D016670,
p-hydroxybenzoic acid ethyl ester 6-guanidinohexanoate,
Ethyl p-(6-guanidinohexanoxyloxy)benzoate methanesulfonate,
Ethyl p-(6-guanidinohexanoyloxy) benzoate methanesulfonate,
Gabexate mesylate, 97%, serine protease inhibitor - 1MG 1mg,
p-Hydroxybenzoic acid ethyl ester 6-guanidinohexanoate mesilate,
4-[[6-[(Aminoiminomethyl)amino]-1-oxohexyl]oxy]benzoic acid ethyl ester,
Benzoic acid, 4-((6-((aminoiminomethyl)amino)-1-oxohexyl)oxy)-, ethyl ester,
Benzoic acid, 4-[[6-[(aminoiminomethyl)amino]-1-oxohexyl]oxy]-, ethyl ester, monomethanesulfonate,